The FDA recently approved Xeomin for use in temporary improvement against glabellar wrinkles (glabella = the area between your eyebrows and above your nose; wrinkles in this area are your frown lines). Similar to Botox and Dysport, Xeomin contains the botulinum toxin. Unlike Botox and Dysport, the toxin itself is naked and not associated with proteins. What this practically means in terms of aesthetic outcome is still unclear. So, the jury’s still out on how Xeomin will fare in comparison to Botox and Dysport. Xeomin will likely widely be available in the spring of 2012. It will be interesting to try it out and see what the key differences are between to botulinum toxins — or maybe they are more similar than dissimilar! Xeomin is manufactured by Merz Aesthetics while Botox is manufactured by Allergan and Dysport by Medicis.
If you enjoyed this article, please consider sharing it!
